Skip to main content
logo
NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.40
+0.14 (0.46%)
At close: Jun 12, 2026, 4:00 PM EDT
31.00
+0.60 (1.97%)
After-hours: Jun 12, 2026, 7:38 PM EDT

NAMS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-214.45-205.53-245.78-176.94-82-32.52
Depreciation & Amortization
0.230.340.240.050.070.02
Stock-Based Compensation
62.2159.4333.6224.574.121.19
Other Adjustments
22.564.3681.985.2373.05-1.65
Changes in Accounts Payable
-1.1813.7-7.455.07-2.179.38
Changes in Accrued Expenses
-8.89--5.47--
Changes in Unearned Revenue
0.96-2.02-3.95-8.7118.43-
Changes in Other Operating Activities
-14.09-13.28-17.464.03-4.46-5.03
Operating Cash Flow
-141.92-143.02-158.81-141.227.03-28.62
Capital Expenditures
-0.27-0.25-0.25-0.02-0.01-0.02
Purchases of Intangible Assets
--4.5----
Purchases of Investments
-349.58-296.73-62.18---
Proceeds from Sale of Investments
160.56122.06----
Other Investing Activities
----0.75-
Investing Cash Flow
-193.78-179.42-62.42-0.020.73-0.02
Issuance of Common Stock
34.0729.52660.58.91394.3578.46
Repurchase of Common Stock
---0.99---
Net Common Stock Issued (Repurchased)
34.0729.52659.518.91394.3578.46
Other Financing Activities
--0.27-0.19--0.07-0.01
Financing Cash Flow
33.829.25659.328.91394.2878.45
Effect of Exchange Rate Changes on Cash and Cash Equivalents
7.6612.76-6.85.055.551.62
Net Cash Flow
-297.13-293.18438.1-132.33402.0449.81
Free Cash Flow
-142.19-143.26-159.05-141.247.02-28.64
FCF Margin
-630.12%-636.63%-349.08%-1002.43%6.83%-
Free Cash Flow Per Share
-1.19-1.21-1.69-1.720.37-1.21
Levered Free Cash Flow
-71.69-207.04-274.65-171.05-70.15-28.18
Unlevered Free Cash Flow
-240.12-228.88-209.31-177.1-59.08-29.59
SEC Filings: 10-K · 10-Q